Posts Tagged Clifton Gooch

Cost of neurological diseases in U.S. approaching $800 billion a year

University of South Florida  study shows research investment critical to prevent destabilizing economic impact TAMPA, FL (March 29, 2017) — More Americans are living longer and surviving chronic […]

Symposium highlights new research by industry leaders seeking first treatment for Friedreich’s ataxia [video]

Hosted by FARA and the USF Ataxia Research Center, the annual scientific symposium emphasizes a patient-centered approach to research For the first time in its seven-year history, the […]

USF Health and FARA to host Sept. 17 scientific symposium

Pharma, biotech leaders will discuss several new clinical studies testing drugs and gene therapy for Friedreich’s ataxia Tampa, FL (Aug. 31, 2015) — The University of South Florida (USF) […]

HeadlineImage

USF Neurology, home of this region’s ALS Center, takes a united Ice Bucket Challenge [VIDEO]

They study, treat, and support every aspect of ALS, so it’s only fitting that the researchers, clinicians and staff from the USF Health Department of Neurology would team […]

HeadlineImage

State funding pushes access to ALS care across Florida

Increased funding helps provide much-needed coordinated care to ALS patients and families across Florida. Access to care truly made a difference to Billie Jean Fogle.  There’s no cure for […]

Scientific symposium covers research behind the “therapeutic revolution” in Friedreich’s ataxia

A record crowd of more than 200 attended the fifth annual Scientific Symposium hosted Sept. 5 by USF and the Friedreich’s Ataxia Research Alliance  (FARA). There was standing […]

HeadlineImage

USF leads national clinical trial testing potential Friedreich’s ataxia drug

Natchez Hanson considers one of her proudest accomplishments walking across the stage to receive her college diploma – earning a bachelor’s degree in math education.   Hansen, 24, now […]

HeadlineImage

USF Multiple Sclerosis Center part of new therapeutic landscape for patients

The same day that the University of South Florida celebrated the 20th anniversary of its USF Multiple Sclerosis Center, the U.S. Food and Drug Administration approved a new […]